AstraZeneca Pharma India plans to launch cancer drug; stock opens positive
AstraZeneca Pharma India plans to launch cancer drug; stock opens positive

AstraZeneca Pharma India plans to launch cancer drug; stock opens positive

Chinmayee D Article rating: 5.0

Acalabrutinib 100 mg capsules (Calquence) are used to treat patients suffering from mantle cell lymphoma (MCL) especially those, who have received at least one prior therapy. It is also used for the treatment of chronic lymphocytic leukaemia (CLL)/small lymphocytic lymphoma (SLL).

Five stocks with buying interest
Five stocks with buying interest

Five stocks with buying interest

Ganesh Pawar Article rating: 4.2

The market opened in green October 16, 2020, overall volumes in futures & options currently stand at 8,37,12,303 contracts with a turnover of Rs. 58,24,762.54 crore.

Five stocks with selling interest
Five stocks with selling interest

Five stocks with selling interest

Ganesh Pawar Article rating: 3.8

The market opened in green October 16, 2020, overall volumes in futures & options currently stand at 8,37,12,303 contracts with a turnover of Rs. 58,24,762.54 crore.

Nifty trend for Friday and stocks in news: Tech Mahindra, Bharti Airtel, AstraZeneca and Persistent Systems
Nifty trend for Friday and stocks in news: Tech Mahindra, Bharti Airtel, AstraZeneca and Persistent Systems

Nifty trend for Friday and stocks in news: Tech Mahindra, Bharti Airtel, AstraZeneca and Persistent Systems

Karan Dsij Article rating: 4.8

Thursday’s market crash proved the age-old saying of D-Street, ‘bulls walk up the stairs, bears jump out of the window’. Nevertheless, on Thursday, Nifty witnessed a scary fall and recorded its biggest single-day fall in percentage terms after May 18.

What is your risk mitigation strategy?
What is your risk mitigation strategy?

What is your risk mitigation strategy?

Shashikant Singh Article rating: 4.3

Deciding the optimal asset allocation and then sticking to it, helps the investors to achieve their financial goals by taking a risk that is manageable.

Sensex & Nifty bleed, banks tumble; Mindtree dips 8.11 per cent, Vodafone Idea plunges 4.88 per cent
Sensex & Nifty bleed, banks tumble; Mindtree dips 8.11 per cent, Vodafone Idea plunges 4.88 per cent

Sensex & Nifty bleed, banks tumble; Mindtree dips 8.11 per cent, Vodafone Idea plunges 4.88 per cent

Ganesh V Article rating: 3.5

Markets were volatile on Wednesday but today i.e. on the expiry day, markets were in control of the bears. Sensex slid by 1,066.33 points or 2.61 per cent to close at 39,728.41 while Nifty declined by 290.70 points or 2.43 per cent to settle at 11,680.35.

RSS
First20742075207620772079208120822083Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR